178 related articles for article (PubMed ID: 9145857)
1. Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.
Nau R; Kinzig-Schippers M; Sörgel F; Schinschke S; Rössing R; Müller C; Kolenda H; Prange HW
Antimicrob Agents Chemother; 1997 May; 41(5):987-91. PubMed ID: 9145857
[TBL] [Abstract][Full Text] [Related]
2. Assessment of biliary excretion of piperacillin-tazobactam in humans.
Westphal JF; Brogard JM; Caro-Sampara F; Adloff M; Blicklé JF; Monteil H; Jehl F
Antimicrob Agents Chemother; 1997 Aug; 41(8):1636-40. PubMed ID: 9257733
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam.
Kim MK; Capitano B; Mattoes HM; Xuan D; Quintiliani R; Nightingale CH; Nicolau DP
Pharmacotherapy; 2002 May; 22(5):569-77. PubMed ID: 12013355
[TBL] [Abstract][Full Text] [Related]
4. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
Tomaselli F; Dittrich P; Maier A; Woltsche M; Matzi V; Pinter J; Nuhsbaumer S; Pinter H; Smolle J; Smolle-Jüttner FM
Br J Clin Pharmacol; 2003 Jun; 55(6):620-4. PubMed ID: 12814459
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers.
Strenkoski-Nix LC; Forrest A; Schentag JJ; Nix DE
J Clin Pharmacol; 1998 Nov; 38(11):1063-71. PubMed ID: 9824789
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.
Nichols K; Chung EK; Knoderer CA; Buenger LE; Healy DP; Dees J; Crumby AS; Kays MB
Antimicrob Agents Chemother; 2016 Jan; 60(1):522-31. PubMed ID: 26552978
[TBL] [Abstract][Full Text] [Related]
7. Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase.
Leleu G; Kitzis MD; Vallois JM; Gutmann L; Decazes JM
Antimicrob Agents Chemother; 1994 Feb; 38(2):195-9. PubMed ID: 8192442
[TBL] [Abstract][Full Text] [Related]
8. [Transferability of tazobactam/piperacillin (TAZ/PIPC) to cerebrospinal fluid of rabbit with meningitis caused by Staphylococcus aureus].
Haruta T; Nishio T; Kobayashi Y
Jpn J Antibiot; 1998 Jun; 51(6):432-6. PubMed ID: 9755832
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery.
Kinzig M; Sörgel F; Brismar B; Nord CE
Antimicrob Agents Chemother; 1992 Sep; 36(9):1997-2004. PubMed ID: 1329637
[TBL] [Abstract][Full Text] [Related]
10. Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis.
Dalla Costa T; Nolting A; Kovar A; Derendorf H
J Antimicrob Chemother; 1998 Dec; 42(6):769-78. PubMed ID: 10052901
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.
Occhipinti DJ; Pendland SL; Schoonover LL; Rypins EB; Danziger LH; Rodvold KA
Antimicrob Agents Chemother; 1997 Nov; 41(11):2511-7. PubMed ID: 9371358
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.
Nau R; Prange HW; Kinzig M; Frank A; Dressel A; Scholz P; Kolenda H; Sörgel F
Antimicrob Agents Chemother; 1996 Mar; 40(3):763-6. PubMed ID: 8851607
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing.
Burgess DS; Waldrep T
Clin Ther; 2002 Jul; 24(7):1090-104. PubMed ID: 12182254
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment.
Derendorf H; Dalla Costa T
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):482-8. PubMed ID: 8937930
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
Varghese JM; Jarrett P; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Apr; 43(4):343-8. PubMed ID: 24612982
[TBL] [Abstract][Full Text] [Related]
16. Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam.
Lister PD; Prevan AM; Sanders CC
Antimicrob Agents Chemother; 1997 Apr; 41(4):721-7. PubMed ID: 9087477
[TBL] [Abstract][Full Text] [Related]
17. Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.
Nau R; Lassek C; Kinzig-Schippers M; Thiel A; Prange HW; Sörgel F
Antimicrob Agents Chemother; 1998 Aug; 42(8):2012-6. PubMed ID: 9687399
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH).
van der Werf TS; Mulder PO; Zijlstra JG; Uges DR; Stegeman CA
Intensive Care Med; 1997 Aug; 23(8):873-7. PubMed ID: 9310805
[TBL] [Abstract][Full Text] [Related]
19. Influence of piperacillin-tazobactam on pharmacokinetics of gentamicin given once daily.
Hitt CM; Patel KB; Nicolau DP; Zhu Z; Nightingale CH
Am J Health Syst Pharm; 1997 Dec; 54(23):2704-8. PubMed ID: 9408514
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis.
Kuti JL; Nightingale CH; Quintiliani R; Nicolau D
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):51-7. PubMed ID: 12376031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
